It was reported via product analysis (pa) that the generator had prematurely depleted.Product analysis was completed on the explanted generator.The pulse generator would not interrogate at the pa lab bench.Therefore, the system diagnostic and final electrical test could not be performed.With the pulse generator case removed and the battery still attached to the pulse generator pcba, the battery measured 0.229 volts, confirming an eos condition.A visual assessment on the pulse generator pcba showed contaminates on the trimmed edge of the pulse generator pcba.Based on the pretemp electrical test (ets 28-0000-6000/3) results, the contamination that was observed on the trimmed edge of the pcba suggest probable electrical paths (resistive path) were established between the copper edges on the trimmed edge of the pcba, which contributed to the supply current conditions.The device history record of the generator was reviewed, and it was confirmed that the device was laser-routed during the manufacturing process.Internal investigation showed that the observed premature battery life indicators were predominately caused by conductive debris from the laser-routing process resulting in leakage paths.No additional relevant information has been received to date.
|
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|